Global Felodipine Extended-Release Tablets Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Glucosamine Sulfate Chondroitin is a dietary supplement commonly used for bone and joint health care, usually used to relieve joint pain and improve joint function. Its main ingredients include glucosamine (Glucosamine) and chondroitin sulfate (Chondroitin Sulfate).
The global Felodipine Extended-Release Tablets market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Felodipine Extended-Release Tablets Industry Forecast” looks at past sales and reviews total world Felodipine Extended-Release Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Felodipine Extended-Release Tablets sales for 2024 through 2030. With Felodipine Extended-Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Felodipine Extended-Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Felodipine Extended-Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Felodipine Extended-Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Felodipine Extended-Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Felodipine Extended-Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Felodipine Extended-Release Tablets.
United States market for Felodipine Extended-Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Felodipine Extended-Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Felodipine Extended-Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Felodipine Extended-Release Tablets players cover Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Felodipine Extended-Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Felodipine Extended-Release Tablets market?
What factors are driving Felodipine Extended-Release Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Felodipine Extended-Release Tablets market opportunities vary by end market size?
How does Felodipine Extended-Release Tablets break out by Type, by Application?
Glucosamine Sulfate Chondroitin is a dietary supplement commonly used for bone and joint health care, usually used to relieve joint pain and improve joint function. Its main ingredients include glucosamine (Glucosamine) and chondroitin sulfate (Chondroitin Sulfate).
The global Felodipine Extended-Release Tablets market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Felodipine Extended-Release Tablets Industry Forecast” looks at past sales and reviews total world Felodipine Extended-Release Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Felodipine Extended-Release Tablets sales for 2024 through 2030. With Felodipine Extended-Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Felodipine Extended-Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Felodipine Extended-Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Felodipine Extended-Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Felodipine Extended-Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Felodipine Extended-Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Felodipine Extended-Release Tablets.
United States market for Felodipine Extended-Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Felodipine Extended-Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Felodipine Extended-Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Felodipine Extended-Release Tablets players cover Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Felodipine Extended-Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablets
- Capsules
- Hospital
- Clinic
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Movefree
- Pfizer
- Watsons
- Doppelherz
- AdvaCare
- By-Health
- Blackmores
- KAL
- Schiff
- Zhejiang Cheng Yi Pharmaceutical
- CSPC
What is the 10-year outlook for the global Felodipine Extended-Release Tablets market?
What factors are driving Felodipine Extended-Release Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Felodipine Extended-Release Tablets market opportunities vary by end market size?
How does Felodipine Extended-Release Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Felodipine Extended-Release Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Felodipine Extended-Release Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Felodipine Extended-Release Tablets by Country/Region, 2019, 2023 & 2030
2.2 Felodipine Extended-Release Tablets Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Felodipine Extended-Release Tablets Sales by Type
2.3.1 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Felodipine Extended-Release Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Felodipine Extended-Release Tablets Sale Price by Type (2019-2024)
2.4 Felodipine Extended-Release Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Felodipine Extended-Release Tablets Sales by Application
2.5.1 Global Felodipine Extended-Release Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Felodipine Extended-Release Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Felodipine Extended-Release Tablets Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Felodipine Extended-Release Tablets Breakdown Data by Company
3.1.1 Global Felodipine Extended-Release Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Felodipine Extended-Release Tablets Sales Market Share by Company (2019-2024)
3.2 Global Felodipine Extended-Release Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Felodipine Extended-Release Tablets Revenue by Company (2019-2024)
3.2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Felodipine Extended-Release Tablets Sale Price by Company
3.4 Key Manufacturers Felodipine Extended-Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Felodipine Extended-Release Tablets Product Location Distribution
3.4.2 Players Felodipine Extended-Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FELODIPINE EXTENDED-RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Felodipine Extended-Release Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Felodipine Extended-Release Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Felodipine Extended-Release Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Felodipine Extended-Release Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Felodipine Extended-Release Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Felodipine Extended-Release Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Felodipine Extended-Release Tablets Sales Growth
4.4 APAC Felodipine Extended-Release Tablets Sales Growth
4.5 Europe Felodipine Extended-Release Tablets Sales Growth
4.6 Middle East & Africa Felodipine Extended-Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Felodipine Extended-Release Tablets Sales by Country
5.1.1 Americas Felodipine Extended-Release Tablets Sales by Country (2019-2024)
5.1.2 Americas Felodipine Extended-Release Tablets Revenue by Country (2019-2024)
5.2 Americas Felodipine Extended-Release Tablets Sales by Type (2019-2024)
5.3 Americas Felodipine Extended-Release Tablets Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Felodipine Extended-Release Tablets Sales by Region
6.1.1 APAC Felodipine Extended-Release Tablets Sales by Region (2019-2024)
6.1.2 APAC Felodipine Extended-Release Tablets Revenue by Region (2019-2024)
6.2 APAC Felodipine Extended-Release Tablets Sales by Type (2019-2024)
6.3 APAC Felodipine Extended-Release Tablets Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Felodipine Extended-Release Tablets by Country
7.1.1 Europe Felodipine Extended-Release Tablets Sales by Country (2019-2024)
7.1.2 Europe Felodipine Extended-Release Tablets Revenue by Country (2019-2024)
7.2 Europe Felodipine Extended-Release Tablets Sales by Type (2019-2024)
7.3 Europe Felodipine Extended-Release Tablets Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Felodipine Extended-Release Tablets by Country
8.1.1 Middle East & Africa Felodipine Extended-Release Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Felodipine Extended-Release Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Felodipine Extended-Release Tablets Sales by Type (2019-2024)
8.3 Middle East & Africa Felodipine Extended-Release Tablets Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Felodipine Extended-Release Tablets
10.3 Manufacturing Process Analysis of Felodipine Extended-Release Tablets
10.4 Industry Chain Structure of Felodipine Extended-Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Felodipine Extended-Release Tablets Distributors
11.3 Felodipine Extended-Release Tablets Customer
12 WORLD FORECAST REVIEW FOR FELODIPINE EXTENDED-RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Felodipine Extended-Release Tablets Market Size Forecast by Region
12.1.1 Global Felodipine Extended-Release Tablets Forecast by Region (2025-2030)
12.1.2 Global Felodipine Extended-Release Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Felodipine Extended-Release Tablets Forecast by Type (2025-2030)
12.7 Global Felodipine Extended-Release Tablets Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Movefree
13.1.1 Movefree Company Information
13.1.2 Movefree Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.1.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Movefree Main Business Overview
13.1.5 Movefree Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.2.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Watsons
13.3.1 Watsons Company Information
13.3.2 Watsons Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.3.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Watsons Main Business Overview
13.3.5 Watsons Latest Developments
13.4 Doppelherz
13.4.1 Doppelherz Company Information
13.4.2 Doppelherz Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.4.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Doppelherz Main Business Overview
13.4.5 Doppelherz Latest Developments
13.5 AdvaCare
13.5.1 AdvaCare Company Information
13.5.2 AdvaCare Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.5.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AdvaCare Main Business Overview
13.5.5 AdvaCare Latest Developments
13.6 By-Health
13.6.1 By-Health Company Information
13.6.2 By-Health Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.6.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 By-Health Main Business Overview
13.6.5 By-Health Latest Developments
13.7 Blackmores
13.7.1 Blackmores Company Information
13.7.2 Blackmores Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.7.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Blackmores Main Business Overview
13.7.5 Blackmores Latest Developments
13.8 KAL
13.8.1 KAL Company Information
13.8.2 KAL Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 KAL Main Business Overview
13.8.5 KAL Latest Developments
13.9 Schiff
13.9.1 Schiff Company Information
13.9.2 Schiff Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.9.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Schiff Main Business Overview
13.9.5 Schiff Latest Developments
13.10 Zhejiang Cheng Yi Pharmaceutical
13.10.1 Zhejiang Cheng Yi Pharmaceutical Company Information
13.10.2 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.10.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Zhejiang Cheng Yi Pharmaceutical Main Business Overview
13.10.5 Zhejiang Cheng Yi Pharmaceutical Latest Developments
13.11 CSPC
13.11.1 CSPC Company Information
13.11.2 CSPC Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.11.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 CSPC Main Business Overview
13.11.5 CSPC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1.Felodipine Extended-ReleaseTablets Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2.Felodipine Extended-ReleaseTablets Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. GlobalFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 6. GlobalFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Table 7. GlobalFelodipine Extended-ReleaseTablets Revenue byType (2019-2024) & ($ million)
Table 8. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share byType (2019-2024)
Table 9. GlobalFelodipine Extended-ReleaseTablets Sale Price byType (2019-2024) & (US$/Unit)
Table 10. GlobalFelodipine Extended-ReleaseTablets Sale by Application (2019-2024) & (K Units)
Table 11. GlobalFelodipine Extended-ReleaseTablets Sale Market Share by Application (2019-2024)
Table 12. GlobalFelodipine Extended-ReleaseTablets Revenue by Application (2019-2024) & ($ million)
Table 13. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Application (2019-2024)
Table 14. GlobalFelodipine Extended-ReleaseTablets Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. GlobalFelodipine Extended-ReleaseTablets Sales by Company (2019-2024) & (K Units)
Table 16. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Company (2019-2024)
Table 17. GlobalFelodipine Extended-ReleaseTablets Revenue by Company (2019-2024) & ($ millions)
Table 18. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Company (2019-2024)
Table 19. GlobalFelodipine Extended-ReleaseTablets Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key ManufacturersFelodipine Extended-ReleaseTablets Producing Area Distribution and Sales Area
Table 21. PlayersFelodipine Extended-ReleaseTablets Products Offered
Table 22.Felodipine Extended-ReleaseTablets Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalFelodipine Extended-ReleaseTablets Sales by Geographic Region (2019-2024) & (K Units)
Table 26. GlobalFelodipine Extended-ReleaseTablets Sales Market Share Geographic Region (2019-2024)
Table 27. GlobalFelodipine Extended-ReleaseTablets Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Geographic Region (2019-2024)
Table 29. GlobalFelodipine Extended-ReleaseTablets Sales by Country/Region (2019-2024) & (K Units)
Table 30. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Country/Region (2019-2024)
Table 31. GlobalFelodipine Extended-ReleaseTablets Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Country/Region (2019-2024)
Table 33. AmericasFelodipine Extended-ReleaseTablets Sales by Country (2019-2024) & (K Units)
Table 34. AmericasFelodipine Extended-ReleaseTablets Sales Market Share by Country (2019-2024)
Table 35. AmericasFelodipine Extended-ReleaseTablets Revenue by Country (2019-2024) & ($ millions)
Table 36. AmericasFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 37. AmericasFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 38. APACFelodipine Extended-ReleaseTablets Sales by Region (2019-2024) & (K Units)
Table 39. APACFelodipine Extended-ReleaseTablets Sales Market Share by Region (2019-2024)
Table 40. APACFelodipine Extended-ReleaseTablets Revenue by Region (2019-2024) & ($ millions)
Table 41. APACFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 42. APACFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 43. EuropeFelodipine Extended-ReleaseTablets Sales by Country (2019-2024) & (K Units)
Table 44. EuropeFelodipine Extended-ReleaseTablets Revenue by Country (2019-2024) & ($ millions)
Table 45. EuropeFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 46. EuropeFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & AfricaFelodipine Extended-ReleaseTablets Revenue Market Share by Country (2019-2024)
Table 49. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 50. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities ofFelodipine Extended-ReleaseTablets
Table 52. Key Market Challenges & Risks ofFelodipine Extended-ReleaseTablets
Table 53. Key IndustryTrends ofFelodipine Extended-ReleaseTablets
Table 54.Felodipine Extended-ReleaseTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Felodipine Extended-ReleaseTablets Distributors List
Table 57.Felodipine Extended-ReleaseTablets Customer List
Table 58. GlobalFelodipine Extended-ReleaseTablets SalesForecast by Region (2025-2030) & (K Units)
Table 59. GlobalFelodipine Extended-ReleaseTablets RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. AmericasFelodipine Extended-ReleaseTablets SalesForecast by Country (2025-2030) & (K Units)
Table 61. AmericasFelodipine Extended-ReleaseTablets Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APACFelodipine Extended-ReleaseTablets SalesForecast by Region (2025-2030) & (K Units)
Table 63. APACFelodipine Extended-ReleaseTablets Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. EuropeFelodipine Extended-ReleaseTablets SalesForecast by Country (2025-2030) & (K Units)
Table 65. EuropeFelodipine Extended-ReleaseTablets RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & AfricaFelodipine Extended-ReleaseTablets SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & AfricaFelodipine Extended-ReleaseTablets RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. GlobalFelodipine Extended-ReleaseTablets SalesForecast byType (2025-2030) & (K Units)
Table 69. GlobalFelodipine Extended-ReleaseTablets RevenueForecast byType (2025-2030) & ($ millions)
Table 70. GlobalFelodipine Extended-ReleaseTablets SalesForecast by Application (2025-2030) & (K Units)
Table 71. GlobalFelodipine Extended-ReleaseTablets RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Movefree Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. MovefreeFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 74. MovefreeFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Movefree Main Business
Table 76. Movefree Latest Developments
Table 77. Pfizer Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. PfizerFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 79. PfizerFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Watsons Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. WatsonsFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 84. WatsonsFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Watsons Main Business
Table 86. Watsons Latest Developments
Table 87. Doppelherz Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. DoppelherzFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 89. DoppelherzFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Doppelherz Main Business
Table 91. Doppelherz Latest Developments
Table 92. AdvaCare Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. AdvaCareFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 94. AdvaCareFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. AdvaCare Main Business
Table 96. AdvaCare Latest Developments
Table 97. By-Health Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. By-HealthFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 99. By-HealthFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. By-Health Main Business
Table 101. By-Health Latest Developments
Table 102. Blackmores Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. BlackmoresFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 104. BlackmoresFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Blackmores Main Business
Table 106. Blackmores Latest Developments
Table 107. KAL Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. KALFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 109. KALFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. KAL Main Business
Table 111. KAL Latest Developments
Table 112. Schiff Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. SchiffFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 114. SchiffFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Schiff Main Business
Table 116. Schiff Latest Developments
Table 117. Zhejiang Cheng Yi Pharmaceutical Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Cheng Yi PharmaceuticalFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 119. Zhejiang Cheng Yi PharmaceuticalFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Zhejiang Cheng Yi Pharmaceutical Main Business
Table 121. Zhejiang Cheng Yi Pharmaceutical Latest Developments
Table 122. CSPC Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. CSPCFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 124. CSPCFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. CSPC Main Business
Table 126. CSPC Latest Developments
LIST OFFIGURES
.
Figure 1. Picture ofFelodipine Extended-ReleaseTablets
Figure 2.Felodipine Extended-ReleaseTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFelodipine Extended-ReleaseTablets Sales Growth Rate 2019-2030 (K Units)
Figure 7. GlobalFelodipine Extended-ReleaseTablets Revenue Growth Rate 2019-2030 ($ millions)
Figure 8.Felodipine Extended-ReleaseTablets Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9.Felodipine Extended-ReleaseTablets Sales Market Share by Country/Region (2023)
Figure 10.Felodipine Extended-ReleaseTablets Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. GlobalFelodipine Extended-ReleaseTablets Sales Market Share byType in 2023
Figure 14. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share byType (2019-2024)
Figure 15.Felodipine Extended-ReleaseTablets Consumed in Hospital
Figure 16. GlobalFelodipine Extended-ReleaseTablets Market: Hospital (2019-2024) & (K Units)
Figure 17.Felodipine Extended-ReleaseTablets Consumed in Clinic
Figure 18. GlobalFelodipine Extended-ReleaseTablets Market: Clinic (2019-2024) & (K Units)
Figure 19.Felodipine Extended-ReleaseTablets Consumed in Pharmacy
Figure 20. GlobalFelodipine Extended-ReleaseTablets Market: Pharmacy (2019-2024) & (K Units)
Figure 21. GlobalFelodipine Extended-ReleaseTablets Sale Market Share by Application (2023)
Figure 22. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Application in 2023
Figure 23.Felodipine Extended-ReleaseTablets Sales by Company in 2023 (K Units)
Figure 24. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Company in 2023
Figure 25.Felodipine Extended-ReleaseTablets Revenue by Company in 2023 ($ millions)
Figure 26. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Company in 2023
Figure 27. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Geographic Region (2019-2024)
Figure 28. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Geographic Region in 2023
Figure 29. AmericasFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 30. AmericasFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 31. APACFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 32. APACFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 33. EuropeFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 34. EuropeFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 35. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 36. Middle East & AfricaFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 37. AmericasFelodipine Extended-ReleaseTablets Sales Market Share by Country in 2023
Figure 38. AmericasFelodipine Extended-ReleaseTablets Revenue Market Share by Country (2019-2024)
Figure 39. AmericasFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 40. AmericasFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 41. United StatesFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 42. CanadaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 43. MexicoFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 44. BrazilFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 45. APACFelodipine Extended-ReleaseTablets Sales Market Share by Region in 2023
Figure 46. APACFelodipine Extended-ReleaseTablets Revenue Market Share by Region (2019-2024)
Figure 47. APACFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 48. APACFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 49. ChinaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 50. JapanFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 51. South KoreaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast AsiaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 53. IndiaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 54. AustraliaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwanFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 56. EuropeFelodipine Extended-ReleaseTablets Sales Market Share by Country in 2023
Figure 57. EuropeFelodipine Extended-ReleaseTablets Revenue Market Share by Country (2019-2024)
Figure 58. EuropeFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 59. EuropeFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 60. GermanyFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 61.FranceFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 62. UKFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 63. ItalyFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 64. RussiaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales Market Share by Country (2019-2024)
Figure 66. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 67. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 68. EgyptFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 69. South AfricaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 70. IsraelFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 71.TurkeyFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC CountriesFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofFelodipine Extended-ReleaseTablets in 2023
Figure 74. Manufacturing Process Analysis ofFelodipine Extended-ReleaseTablets
Figure 75. Industry Chain Structure ofFelodipine Extended-ReleaseTablets
Figure 76. Channels of Distribution
Figure 77. GlobalFelodipine Extended-ReleaseTablets Sales MarketForecast by Region (2025-2030)
Figure 78. GlobalFelodipine Extended-ReleaseTablets Revenue Market ShareForecast by Region (2025-2030)
Figure 79. GlobalFelodipine Extended-ReleaseTablets Sales Market ShareForecast byType (2025-2030)
Figure 80. GlobalFelodipine Extended-ReleaseTablets Revenue Market ShareForecast byType (2025-2030)
Figure 81. GlobalFelodipine Extended-ReleaseTablets Sales Market ShareForecast by Application (2025-2030)
Figure 82. GlobalFelodipine Extended-ReleaseTablets Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Felodipine Extended-Release Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Felodipine Extended-Release Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Felodipine Extended-Release Tablets by Country/Region, 2019, 2023 & 2030
2.2 Felodipine Extended-Release Tablets Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Felodipine Extended-Release Tablets Sales by Type
2.3.1 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Felodipine Extended-Release Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Felodipine Extended-Release Tablets Sale Price by Type (2019-2024)
2.4 Felodipine Extended-Release Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Felodipine Extended-Release Tablets Sales by Application
2.5.1 Global Felodipine Extended-Release Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Felodipine Extended-Release Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Felodipine Extended-Release Tablets Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Felodipine Extended-Release Tablets Breakdown Data by Company
3.1.1 Global Felodipine Extended-Release Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Felodipine Extended-Release Tablets Sales Market Share by Company (2019-2024)
3.2 Global Felodipine Extended-Release Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Felodipine Extended-Release Tablets Revenue by Company (2019-2024)
3.2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Felodipine Extended-Release Tablets Sale Price by Company
3.4 Key Manufacturers Felodipine Extended-Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Felodipine Extended-Release Tablets Product Location Distribution
3.4.2 Players Felodipine Extended-Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FELODIPINE EXTENDED-RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Felodipine Extended-Release Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Felodipine Extended-Release Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Felodipine Extended-Release Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Felodipine Extended-Release Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Felodipine Extended-Release Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Felodipine Extended-Release Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Felodipine Extended-Release Tablets Sales Growth
4.4 APAC Felodipine Extended-Release Tablets Sales Growth
4.5 Europe Felodipine Extended-Release Tablets Sales Growth
4.6 Middle East & Africa Felodipine Extended-Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Felodipine Extended-Release Tablets Sales by Country
5.1.1 Americas Felodipine Extended-Release Tablets Sales by Country (2019-2024)
5.1.2 Americas Felodipine Extended-Release Tablets Revenue by Country (2019-2024)
5.2 Americas Felodipine Extended-Release Tablets Sales by Type (2019-2024)
5.3 Americas Felodipine Extended-Release Tablets Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Felodipine Extended-Release Tablets Sales by Region
6.1.1 APAC Felodipine Extended-Release Tablets Sales by Region (2019-2024)
6.1.2 APAC Felodipine Extended-Release Tablets Revenue by Region (2019-2024)
6.2 APAC Felodipine Extended-Release Tablets Sales by Type (2019-2024)
6.3 APAC Felodipine Extended-Release Tablets Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Felodipine Extended-Release Tablets by Country
7.1.1 Europe Felodipine Extended-Release Tablets Sales by Country (2019-2024)
7.1.2 Europe Felodipine Extended-Release Tablets Revenue by Country (2019-2024)
7.2 Europe Felodipine Extended-Release Tablets Sales by Type (2019-2024)
7.3 Europe Felodipine Extended-Release Tablets Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Felodipine Extended-Release Tablets by Country
8.1.1 Middle East & Africa Felodipine Extended-Release Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Felodipine Extended-Release Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Felodipine Extended-Release Tablets Sales by Type (2019-2024)
8.3 Middle East & Africa Felodipine Extended-Release Tablets Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Felodipine Extended-Release Tablets
10.3 Manufacturing Process Analysis of Felodipine Extended-Release Tablets
10.4 Industry Chain Structure of Felodipine Extended-Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Felodipine Extended-Release Tablets Distributors
11.3 Felodipine Extended-Release Tablets Customer
12 WORLD FORECAST REVIEW FOR FELODIPINE EXTENDED-RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Felodipine Extended-Release Tablets Market Size Forecast by Region
12.1.1 Global Felodipine Extended-Release Tablets Forecast by Region (2025-2030)
12.1.2 Global Felodipine Extended-Release Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Felodipine Extended-Release Tablets Forecast by Type (2025-2030)
12.7 Global Felodipine Extended-Release Tablets Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Movefree
13.1.1 Movefree Company Information
13.1.2 Movefree Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.1.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Movefree Main Business Overview
13.1.5 Movefree Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.2.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Watsons
13.3.1 Watsons Company Information
13.3.2 Watsons Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.3.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Watsons Main Business Overview
13.3.5 Watsons Latest Developments
13.4 Doppelherz
13.4.1 Doppelherz Company Information
13.4.2 Doppelherz Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.4.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Doppelherz Main Business Overview
13.4.5 Doppelherz Latest Developments
13.5 AdvaCare
13.5.1 AdvaCare Company Information
13.5.2 AdvaCare Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.5.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AdvaCare Main Business Overview
13.5.5 AdvaCare Latest Developments
13.6 By-Health
13.6.1 By-Health Company Information
13.6.2 By-Health Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.6.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 By-Health Main Business Overview
13.6.5 By-Health Latest Developments
13.7 Blackmores
13.7.1 Blackmores Company Information
13.7.2 Blackmores Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.7.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Blackmores Main Business Overview
13.7.5 Blackmores Latest Developments
13.8 KAL
13.8.1 KAL Company Information
13.8.2 KAL Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 KAL Main Business Overview
13.8.5 KAL Latest Developments
13.9 Schiff
13.9.1 Schiff Company Information
13.9.2 Schiff Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.9.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Schiff Main Business Overview
13.9.5 Schiff Latest Developments
13.10 Zhejiang Cheng Yi Pharmaceutical
13.10.1 Zhejiang Cheng Yi Pharmaceutical Company Information
13.10.2 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.10.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Zhejiang Cheng Yi Pharmaceutical Main Business Overview
13.10.5 Zhejiang Cheng Yi Pharmaceutical Latest Developments
13.11 CSPC
13.11.1 CSPC Company Information
13.11.2 CSPC Felodipine Extended-Release Tablets Product Portfolios and Specifications
13.11.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 CSPC Main Business Overview
13.11.5 CSPC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1.Felodipine Extended-ReleaseTablets Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2.Felodipine Extended-ReleaseTablets Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. GlobalFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 6. GlobalFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Table 7. GlobalFelodipine Extended-ReleaseTablets Revenue byType (2019-2024) & ($ million)
Table 8. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share byType (2019-2024)
Table 9. GlobalFelodipine Extended-ReleaseTablets Sale Price byType (2019-2024) & (US$/Unit)
Table 10. GlobalFelodipine Extended-ReleaseTablets Sale by Application (2019-2024) & (K Units)
Table 11. GlobalFelodipine Extended-ReleaseTablets Sale Market Share by Application (2019-2024)
Table 12. GlobalFelodipine Extended-ReleaseTablets Revenue by Application (2019-2024) & ($ million)
Table 13. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Application (2019-2024)
Table 14. GlobalFelodipine Extended-ReleaseTablets Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. GlobalFelodipine Extended-ReleaseTablets Sales by Company (2019-2024) & (K Units)
Table 16. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Company (2019-2024)
Table 17. GlobalFelodipine Extended-ReleaseTablets Revenue by Company (2019-2024) & ($ millions)
Table 18. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Company (2019-2024)
Table 19. GlobalFelodipine Extended-ReleaseTablets Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key ManufacturersFelodipine Extended-ReleaseTablets Producing Area Distribution and Sales Area
Table 21. PlayersFelodipine Extended-ReleaseTablets Products Offered
Table 22.Felodipine Extended-ReleaseTablets Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalFelodipine Extended-ReleaseTablets Sales by Geographic Region (2019-2024) & (K Units)
Table 26. GlobalFelodipine Extended-ReleaseTablets Sales Market Share Geographic Region (2019-2024)
Table 27. GlobalFelodipine Extended-ReleaseTablets Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Geographic Region (2019-2024)
Table 29. GlobalFelodipine Extended-ReleaseTablets Sales by Country/Region (2019-2024) & (K Units)
Table 30. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Country/Region (2019-2024)
Table 31. GlobalFelodipine Extended-ReleaseTablets Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Country/Region (2019-2024)
Table 33. AmericasFelodipine Extended-ReleaseTablets Sales by Country (2019-2024) & (K Units)
Table 34. AmericasFelodipine Extended-ReleaseTablets Sales Market Share by Country (2019-2024)
Table 35. AmericasFelodipine Extended-ReleaseTablets Revenue by Country (2019-2024) & ($ millions)
Table 36. AmericasFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 37. AmericasFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 38. APACFelodipine Extended-ReleaseTablets Sales by Region (2019-2024) & (K Units)
Table 39. APACFelodipine Extended-ReleaseTablets Sales Market Share by Region (2019-2024)
Table 40. APACFelodipine Extended-ReleaseTablets Revenue by Region (2019-2024) & ($ millions)
Table 41. APACFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 42. APACFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 43. EuropeFelodipine Extended-ReleaseTablets Sales by Country (2019-2024) & (K Units)
Table 44. EuropeFelodipine Extended-ReleaseTablets Revenue by Country (2019-2024) & ($ millions)
Table 45. EuropeFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 46. EuropeFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & AfricaFelodipine Extended-ReleaseTablets Revenue Market Share by Country (2019-2024)
Table 49. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales byType (2019-2024) & (K Units)
Table 50. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities ofFelodipine Extended-ReleaseTablets
Table 52. Key Market Challenges & Risks ofFelodipine Extended-ReleaseTablets
Table 53. Key IndustryTrends ofFelodipine Extended-ReleaseTablets
Table 54.Felodipine Extended-ReleaseTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Felodipine Extended-ReleaseTablets Distributors List
Table 57.Felodipine Extended-ReleaseTablets Customer List
Table 58. GlobalFelodipine Extended-ReleaseTablets SalesForecast by Region (2025-2030) & (K Units)
Table 59. GlobalFelodipine Extended-ReleaseTablets RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. AmericasFelodipine Extended-ReleaseTablets SalesForecast by Country (2025-2030) & (K Units)
Table 61. AmericasFelodipine Extended-ReleaseTablets Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APACFelodipine Extended-ReleaseTablets SalesForecast by Region (2025-2030) & (K Units)
Table 63. APACFelodipine Extended-ReleaseTablets Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. EuropeFelodipine Extended-ReleaseTablets SalesForecast by Country (2025-2030) & (K Units)
Table 65. EuropeFelodipine Extended-ReleaseTablets RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & AfricaFelodipine Extended-ReleaseTablets SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & AfricaFelodipine Extended-ReleaseTablets RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. GlobalFelodipine Extended-ReleaseTablets SalesForecast byType (2025-2030) & (K Units)
Table 69. GlobalFelodipine Extended-ReleaseTablets RevenueForecast byType (2025-2030) & ($ millions)
Table 70. GlobalFelodipine Extended-ReleaseTablets SalesForecast by Application (2025-2030) & (K Units)
Table 71. GlobalFelodipine Extended-ReleaseTablets RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Movefree Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. MovefreeFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 74. MovefreeFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Movefree Main Business
Table 76. Movefree Latest Developments
Table 77. Pfizer Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. PfizerFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 79. PfizerFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Watsons Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. WatsonsFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 84. WatsonsFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Watsons Main Business
Table 86. Watsons Latest Developments
Table 87. Doppelherz Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. DoppelherzFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 89. DoppelherzFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Doppelherz Main Business
Table 91. Doppelherz Latest Developments
Table 92. AdvaCare Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. AdvaCareFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 94. AdvaCareFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. AdvaCare Main Business
Table 96. AdvaCare Latest Developments
Table 97. By-Health Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. By-HealthFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 99. By-HealthFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. By-Health Main Business
Table 101. By-Health Latest Developments
Table 102. Blackmores Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. BlackmoresFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 104. BlackmoresFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Blackmores Main Business
Table 106. Blackmores Latest Developments
Table 107. KAL Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. KALFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 109. KALFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. KAL Main Business
Table 111. KAL Latest Developments
Table 112. Schiff Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. SchiffFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 114. SchiffFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Schiff Main Business
Table 116. Schiff Latest Developments
Table 117. Zhejiang Cheng Yi Pharmaceutical Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Cheng Yi PharmaceuticalFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 119. Zhejiang Cheng Yi PharmaceuticalFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Zhejiang Cheng Yi Pharmaceutical Main Business
Table 121. Zhejiang Cheng Yi Pharmaceutical Latest Developments
Table 122. CSPC Basic Information,Felodipine Extended-ReleaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. CSPCFelodipine Extended-ReleaseTablets Product Portfolios and Specifications
Table 124. CSPCFelodipine Extended-ReleaseTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. CSPC Main Business
Table 126. CSPC Latest Developments
LIST OFFIGURES
.
Figure 1. Picture ofFelodipine Extended-ReleaseTablets
Figure 2.Felodipine Extended-ReleaseTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFelodipine Extended-ReleaseTablets Sales Growth Rate 2019-2030 (K Units)
Figure 7. GlobalFelodipine Extended-ReleaseTablets Revenue Growth Rate 2019-2030 ($ millions)
Figure 8.Felodipine Extended-ReleaseTablets Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9.Felodipine Extended-ReleaseTablets Sales Market Share by Country/Region (2023)
Figure 10.Felodipine Extended-ReleaseTablets Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. GlobalFelodipine Extended-ReleaseTablets Sales Market Share byType in 2023
Figure 14. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share byType (2019-2024)
Figure 15.Felodipine Extended-ReleaseTablets Consumed in Hospital
Figure 16. GlobalFelodipine Extended-ReleaseTablets Market: Hospital (2019-2024) & (K Units)
Figure 17.Felodipine Extended-ReleaseTablets Consumed in Clinic
Figure 18. GlobalFelodipine Extended-ReleaseTablets Market: Clinic (2019-2024) & (K Units)
Figure 19.Felodipine Extended-ReleaseTablets Consumed in Pharmacy
Figure 20. GlobalFelodipine Extended-ReleaseTablets Market: Pharmacy (2019-2024) & (K Units)
Figure 21. GlobalFelodipine Extended-ReleaseTablets Sale Market Share by Application (2023)
Figure 22. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Application in 2023
Figure 23.Felodipine Extended-ReleaseTablets Sales by Company in 2023 (K Units)
Figure 24. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Company in 2023
Figure 25.Felodipine Extended-ReleaseTablets Revenue by Company in 2023 ($ millions)
Figure 26. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Company in 2023
Figure 27. GlobalFelodipine Extended-ReleaseTablets Sales Market Share by Geographic Region (2019-2024)
Figure 28. GlobalFelodipine Extended-ReleaseTablets Revenue Market Share by Geographic Region in 2023
Figure 29. AmericasFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 30. AmericasFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 31. APACFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 32. APACFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 33. EuropeFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 34. EuropeFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 35. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales 2019-2024 (K Units)
Figure 36. Middle East & AfricaFelodipine Extended-ReleaseTablets Revenue 2019-2024 ($ millions)
Figure 37. AmericasFelodipine Extended-ReleaseTablets Sales Market Share by Country in 2023
Figure 38. AmericasFelodipine Extended-ReleaseTablets Revenue Market Share by Country (2019-2024)
Figure 39. AmericasFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 40. AmericasFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 41. United StatesFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 42. CanadaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 43. MexicoFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 44. BrazilFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 45. APACFelodipine Extended-ReleaseTablets Sales Market Share by Region in 2023
Figure 46. APACFelodipine Extended-ReleaseTablets Revenue Market Share by Region (2019-2024)
Figure 47. APACFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 48. APACFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 49. ChinaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 50. JapanFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 51. South KoreaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast AsiaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 53. IndiaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 54. AustraliaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwanFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 56. EuropeFelodipine Extended-ReleaseTablets Sales Market Share by Country in 2023
Figure 57. EuropeFelodipine Extended-ReleaseTablets Revenue Market Share by Country (2019-2024)
Figure 58. EuropeFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 59. EuropeFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 60. GermanyFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 61.FranceFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 62. UKFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 63. ItalyFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 64. RussiaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales Market Share by Country (2019-2024)
Figure 66. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales Market Share byType (2019-2024)
Figure 67. Middle East & AfricaFelodipine Extended-ReleaseTablets Sales Market Share by Application (2019-2024)
Figure 68. EgyptFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 69. South AfricaFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 70. IsraelFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 71.TurkeyFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC CountriesFelodipine Extended-ReleaseTablets Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofFelodipine Extended-ReleaseTablets in 2023
Figure 74. Manufacturing Process Analysis ofFelodipine Extended-ReleaseTablets
Figure 75. Industry Chain Structure ofFelodipine Extended-ReleaseTablets
Figure 76. Channels of Distribution
Figure 77. GlobalFelodipine Extended-ReleaseTablets Sales MarketForecast by Region (2025-2030)
Figure 78. GlobalFelodipine Extended-ReleaseTablets Revenue Market ShareForecast by Region (2025-2030)
Figure 79. GlobalFelodipine Extended-ReleaseTablets Sales Market ShareForecast byType (2025-2030)
Figure 80. GlobalFelodipine Extended-ReleaseTablets Revenue Market ShareForecast byType (2025-2030)
Figure 81. GlobalFelodipine Extended-ReleaseTablets Sales Market ShareForecast by Application (2025-2030)
Figure 82. GlobalFelodipine Extended-ReleaseTablets Revenue Market ShareForecast by Application (2025-2030)
